Secondary Cluster Headache: A Presentation of Cerebral Venous Thrombosis

Peterlin, B. Lee; Levin, Morris; Cohen, JA; Ward, TN

doi:10.1111/j.1468-2982.2006.01135.x

Cited by 11 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The patient was discharged after undergoing anticoagulation treatment and was followed up for 18 months without headache. Other authors have reported similar findings (Peterlin et al, 2006 ; Bellamio et al, 2017 ).…”

Section: Clinical Featuressupporting

confidence: 74%

Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review

Luo

Tian

Wang

2018

Front. Aging Neurosci.

128

145

View full text Add to dashboard Cite

Cerebral venous thrombosis (CVT), also called cerebral venous sinus thrombosis (CVST), is a cerebrovascular disease with diverse clinical manifestations that often affects young adults, women of childbearing age, and children. It's most common clinical manifestations are headache, seizures, altered consciousness, and neurological focal signs on physical examination. CVT can manifest as a single symptom, or it can present as a syndrome consisting of multiple symptoms. This non-specific clinical picture makes diagnosing CVT difficult. Although the mortality rate of CVT has been significantly reduced by improvements in treatment and diagnostic techniques, the mortality rate of severe CVT remains as high as 34.2%. Survivors of this type of CVT have varying degrees of residual symptoms and are not able to return to their previous work. Hence, we performed a comprehensive literature search in the PubMed, EMBASE, and Medline databases to review the diagnosis and treatment of CVT.

show abstract

Section: Clinical Featuressupporting

confidence: 74%

Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review

Luo

Tian

Wang

2018

Front. Aging Neurosci.

128

145

View full text Add to dashboard Cite

show abstract

“…In our case, pathophysiology of CLH could potentially result from several mechanisms including obstruction of the SSS, arterio‐veinous shunt, and/or meningeal inflammation. Several cases of CLH have been reported secondary to cerebral venous thrombosis . In our case, the fact that attacks occurred especially during effort and decreased after SSS re‐permeabilization suggests that CLH was related to SSS obstruction.…”

Section: Discussionmentioning

confidence: 56%

Cluster‐Like Headache Secondary to Parasagittal Hemangiopericytoma

et al. 2012

View full text Add to dashboard Cite

We describe an original case of cluster-like headache CLH) revealing a parasagittal tumor invading the superior sagittal sinus (SSS). Resection of the tumor (hemangiopericytoma) allowed the re-permeabilization of the SSS and was followed by the complete disappearance of CLH. Several mechanisms including obstruction of the SSS, hypervascularization with arterio-veinous shunt, and overflow in the cavernous sinus might explain the symptoms.

show abstract

“…The role of inflammation in PMS was further supported by studies of premenstrual exacerbation of asthma, in which increased levels of airway inflammation during the late luteal phase were associated with worsening of symptoms 12 . CRP, TNF-α and IL-6 have been positively associated with migraine headache, a usual symptom of PMS 22 .…”

Section: Discussionmentioning

confidence: 97%

Vitamin D Supplementation for Premenstrual Syndrome-Related inflammation and antioxidant markers in students with vitamin D deficient: a randomized clinical trial

Heidari

Amani

Feizi

et al. 2019

Sci Rep

View full text Add to dashboard Cite

Premenstrual syndrome (PMS) is a common disorder in the reproductive age that negatively significant impacts on women’s quality of life. This randomized clinical trial study was undertaken to investigate the effect of vitamin D supplementation on inflammatory and antioxidant markers in 44 vitamin D deficient (25(OH)D < 20 ng/mL) students with PMS. Participants received either 50,000 IU vitamin D3 or a placebo pearl fortnightly for 4 months. At the baseline and in the last 2 months of intervention, participants were asked to complete the PMS Daily Symptoms Rating form along with taking the pearls and their blood samples were collected to assess serum levels of 25(OH)D3, Interleukin10 and 12 (IL-10, IL-12) and total antioxidant capacity (TAC). In vitamin D group, serum levels of IL-10 and IL-12 significantly decreased while TAC significantly increased post-intervention. There were significant differences regarding serum IL-12 and TAC levels between the two groups. Mean score of the total PMS symptoms showed significant improvement in 25(OH)D. Vitamin D supplementation seems to be an effective strategy to improve inflammation and antioxidant markers in vitamin D deficient women with PMS. This clinical trial was registered at Iranian Registry of Clinical Trials on 20/06/2018 (IRCT20180525039822N1).

show abstract

Secondary Cluster Headache: A Presentation of Cerebral Venous Thrombosis

Cited by 11 publications

References 7 publications

Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review

Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review

Cluster‐Like Headache Secondary to Parasagittal Hemangiopericytoma

Vitamin D Supplementation for Premenstrual Syndrome-Related inflammation and antioxidant markers in students with vitamin D deficient: a randomized clinical trial

Contact Info

Product

Resources

About